Targeted Therapeutic Strategies for Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, which is characterized by the absence of estrogen receptor (ER) and progesterone receptor (PR) expression and the absence of human epidermal growth factor receptor 2 (HER2) expression/amplification. Conventional ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ying, Zhan, Zhijun, Yin, Xuemin, Fu, Shujun, Deng, Xiyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581040/
https://www.ncbi.nlm.nih.gov/pubmed/34778045
http://dx.doi.org/10.3389/fonc.2021.731535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581040/
https://www.ncbi.nlm.nih.gov/pubmed/34778045
http://dx.doi.org/10.3389/fonc.2021.731535

Ejemplares similares